A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?

por Shields, Adrian M., Panayi, Gabriel S., Corrigall, Valerie M.
Publicado 2012

Binding immunoglobulin protein resolves rheumatoid synovitis: a xenogeneic study using rheumatoid arthritis synovial membrane transplants in SCID mice

por Yoshida, Kaoru, Ochiai, Akira, Matsuno, Hiroaki, Panayi, Gabriel S, Corrigall, Valerie M
Publicado 2011

Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years

por Gullick, Nicola J., Oakley, Stephen P., Zain, Amir, Gibson, Terence, Jones, Tim, Mistlin, Alan, Rees, Jonathan D., Panayi, Gabriel S., Kirkham, Bruce W.
Publicado 2012

Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis

por Gullick, Nicola J., Ibrahim, Fowzia, Scott, Ian C., Vincent, Alexandra, Cope, Andrew P., Garrood, Toby, Panayi, Gabriel S., Scott, David L., Kirkham, Bruce W.
Publicado 2019

Binding Immunoglobulin Protein (BIP) Inhibits TNF‐α–Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis Model

por Zaiss, Mario M., Hall, Christopher, McGowan, Neil W. A., Babb, Rebecca, Devlia, Vikesh, Lucas, Sébastien, Meghji, Sajeda, Henderson, Brian, Bozec, Aline, Schett, Georg, David, Jean‐Pierre, Panayi, Gabriel S., Grigoriadis, Agamemnon E., Corrigall, Valerie M.
Publicado 2019